LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LUNG CANCER FOUNDATION OF AMERICA, founded in 2007, is a community nonprofit in the Diseases & Disorders sector that reported $2.3M in total revenue in fiscal year 2024. Expenses of $2.1M left a modest 10% surplus.
LUNG CANCER FOUNDATION OF AMERICA (LCFA) IS WORKING TO CHANGE THE PUBLIC PERCEPTION OF LUNG CANCER THROUGH EDUCATION AND PERSONAL STORIES ABOUT LUNG CANCER AND TO IMPROVE PATIENT OUTCOMES THROUGH FUNDING IMPACTFUL RESEARCH.
RESEARCH GRANT & SCIENTIFIC ADVANCMENTS: RESEARCH GRANTS: AWARDED MULTIPLE SIX-FIGURE LUNG CANCER RESEARCH GRANTS TO YOUNG INVESTIGATORS, FOCUSING ON EARLY DETECTION, TARGETED THERAPIES, AND...
RESEARCH GRANT & SCIENTIFIC ADVANCMENTS: RESEARCH GRANTS: AWARDED MULTIPLE SIX-FIGURE LUNG CANCER RESEARCH GRANTS TO YOUNG INVESTIGATORS, FOCUSING ON EARLY DETECTION, TARGETED THERAPIES, AND IMMUNOTHERAPY. THESE GRANTS, MADE POSSIBLE THROUGH GENEROUS PRIVATE DONATIONS, HAVE LED TO GROUNDBREAKING DISCOVERIES IN LUNG CANCER TREATMENT. SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC).
AWARENESS INITIATIVES, SPEAKERS BUREAU, FUNDRAISING SUCCESS, & COLLABORATIVE PARTNERSHIPS: AWARENESS INITIATIVES: REACHED MILLIONS OF PEOPLE THROUGH COMPREHENSIVE AWARENESS-RAISING CAMPAIGNS...
AWARENESS INITIATIVES, SPEAKERS BUREAU, FUNDRAISING SUCCESS, & COLLABORATIVE PARTNERSHIPS: AWARENESS INITIATIVES: REACHED MILLIONS OF PEOPLE THROUGH COMPREHENSIVE AWARENESS-RAISING CAMPAIGNS, EDUCATING THE PUBLIC ABOUT LUNG CANCER RISK FACTORS, EARLY DETECTION, AND TREATMENT OPTIONS.SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC). FUNDRAISING SUCCESS: SUCCESSFULLY RAISED FUNDS TO SUPPORT ONGOING RESEARCH INITIATIVES AND AWARENESS PROGRAMS, DEMONSTRATING STRONG DONOR ENGAGEMENT AND FINANCIAL STEWARDSHIP. COLLABORATIVE PARTNERSHIPS: STRENGTHENED PARTNERSHIPS WITH SISTER ORGANIZATIONS TO MAXIMIZE THE IMPACT OF RESEARCH FUNDING AND ADVOCACY EFFORTS. THROUGH THESE ACCOMPLISHMENTS, LCFA HAS CONTINUED TO MAKE SIGNIFICANT STRIDES IN IMPROVING LUNG CANCER OUTCOMES AND SUPPORTING THE LUNG CANCER COMMUNITY.
COMMUNITY ENGAGEMENT: FOSTERED A SUPPORTIVE COMMUNITY FOR LUNG CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATIONAL RESOURCES, SUPPORT PROGRAMS, AND ADVOCACY EFFORTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $2,334,021 | $2,265,637 | +0.0% |
| Expenses | $2,096,572 | $1,854,172 | +0.1% |
| Net Income | $237,449 | $411,465 | -0.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JIM BARANSKI | EXECUTIVE DIRECTOR | 40.00 |
Officer
Director
|
$200,000 | $8,002 | $208,002 |
| KIM NORRIS | PRESIDENT | 40.00 |
Officer
Director
|
$100,000 | $5,702 | $105,702 |
| SUSAN MANDEL MD | SECRETARY | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARTA KAUFFMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT FIGLIN MD FACP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID T LEVINSON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARTIN EDELMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CAROLYN ZAINER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE SAYER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TRISH COURY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $2,334,021 | $2,096,572 | $2,114,168 | $237,449 |
| 2023 | $2,265,637 | $1,854,172 | $1,548,034 | $411,465 |
| 2022 | $1,540,536 | $1,548,582 | $1,180,746 | $-8,046 |
| 2021 | $1,298,335 | $1,089,710 | $1,303,793 | $208,625 |
| 2020 | $1,432,839 | $1,351,529 | $1,558,916 | $81,310 |
| 2019 | $1,003,191 | $1,308,962 | $1,317,950 | $-305,771 |
| 2018 | $1,353,237 | $1,085,709 | $1,316,759 | $267,528 |
Compare LUNG CANCER FOUNDATION OF AMERICA with other nonprofits in California and across the country.